News Releases
Aethlon Medical to Present at the B. Riley 11th Annual Investor ConferenceSan Diego, May 25, 2010 – Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced that James A. Joyce, Chairman and Chief Executive Officer of Aethlon Medical, Inc., will present at the B. Riley 11th Annual Investor Conference on May 26, 2010, at 4:00 p.m. Pacific Time. Investors are urged to listen to the live webcast at: http://www.wsw.com/webcast/brileyco14/aemd.ob/. About Aethlon Medical Aethlon Medical, Inc. creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our lead product, the Hemopurifier® is the first-in-class medical device to selectively capture circulating viruses and immunosuppressive proteins prior to cell and organ infection. Human studies have documented the ability of our Hemopurifier® to reduce viral load in patients infected with Hepatitis-C virus (HCV) and the Human Immunodeficiency Virus (HIV). Our primary clinical and commercialization focus is to establish the Hemopurifier® as an adjunct therapy to enhance and prolong the benefit of traditional infectious disease drug regimens. Contacts: Jim Joyce Chairman, CEO 858.459.7800 x301
John P. Salvador 858.459.7800 x 307 jps@aethlonmedical.com |
